{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih4svhynovc4r3elydnk6s3lor2xjznoomiqynnupc7zy4d33q3ey",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mf4zhqko4pw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibhqix4qbtir52lqzx43dvjoo6ybavzrsxqiw36aela54rct5npjm"
    },
    "mimeType": "image/jpeg",
    "size": 62167
  },
  "path": "/2026/02/18/korsana-biosciences-alzheimers-brain-shuttles/?utm_campaign=rss",
  "publishedAt": "2026-02-18T11:00:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Alzheimer’s",
    "biotechnology",
    "dementia",
    "drug development",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "Is there room for more Alzheimer’s antibody therapies on the market? Korsana Biosciences' investors think so.",
  "title": "STAT+: Biotech startup raises $175 million to advance Alzheimer’s antibody therapy",
  "updatedAt": "2026-02-18T03:36:46.000Z"
}